NCT00751829View on ClinicalTrials.gov

Isolated Systolic Hypertension in the Elderly and Very Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

February 28, 2005

Conditions
Isolated Systolic Hypertension
Interventions
DRUG

olmesartan medoxomil + hydrochlorothiazide, if necessary

oral olmesartan medoxomil tablets 20 mg or 40 mg once daily for 24 weeks + oral hydrochlorothiazide tablets 12.5 or 25 mg once daily after 12 weeks, if needed to control BP

DRUG

nitrendipine + hydrochlorothiazide, if necessary

oral nitrendipine tablets 10 or 20 mg taken twice daily for 24 weeks + oral hydrochlorothiazide tablets 12.5 or 25 mg once daily after 12 weeks, if needed to control BP

Trial Locations (1)

Unknown

Munich

All Listed Sponsors
lead

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

INDUSTRY

NCT00751829 - Isolated Systolic Hypertension in the Elderly and Very Elderly | Biotech Hunter | Biotech Hunter